1. Home
  2. AMBQ vs VALN Comparison

AMBQ vs VALN Comparison

Compare AMBQ & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AMBQ

Ambiq Micro Inc.

HOLD

Current Price

$81.66

Market Cap

594.9M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.13

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBQ
VALN
Founded
2010
2012
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
594.9M
495.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AMBQ
VALN
Price
$81.66
$5.13
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$42.20
$15.50
AVG Volume (30 Days)
735.5K
19.9K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.81
N/A
Revenue Next Year
$27.98
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.12
$5.04
52 Week High
$91.61
$12.25

Technical Indicators

Market Signals
Indicator
AMBQ
VALN
Relative Strength Index (RSI) 51.24 42.47
Support Level $73.59 $5.10
Resistance Level $88.50 $5.52
Average True Range (ATR) 6.24 0.20
MACD -0.87 0.01
Stochastic Oscillator 47.07 18.00

Price Performance

Historical Comparison
AMBQ
VALN

About AMBQ Ambiq Micro Inc.

Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: